Andrew I Koven is of Kala Pharmaceuticals, Inc.. Currently has a direct ownership of 16,972 shares of KALA, which is worth approximately $119,313. The most recent transaction as insider was on Jun 15, 2025, when has been sold 3,050 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17K
21.91% 3M change
21.91% 12M change
Total Value Held $119,313

ANDREW I KOVEN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 15 2025
BUY
Grant, award, or other acquisition
-
3,050 Added 15.23%
16,972 Common Stock
Jun 11 2024
BUY
Grant, award, or other acquisition
-
1,750 Added 11.17%
13,922 Common Stock
Jun 22 2023
BUY
Grant, award, or other acquisition
-
8,915 Added 42.28%
12,172 Common Stock
May 31 2023
BUY
Grant, award, or other acquisition
-
2,197 Added 40.28%
3,257 Common Stock
Jun 17 2021
BUY
Grant, award, or other acquisition
-
25,000 Added 32.05%
53,000 Common Stock

Also insider at

NRBO
NeuroBo Pharmaceuticals, Inc. Healthcare
AIK

Andrew I Koven

Watertown, MA

Track Institutional and Insider Activities on KALA

Follow Kala Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KALA shares.

Notify only if

Insider Trading

Get notified when an Kala Pharmaceuticals, Inc. insider buys or sells KALA shares.

Notify only if

News

Receive news related to Kala Pharmaceuticals, Inc.

Track Activities on KALA